NCT06910657 2026-03-02IDOV-Immune for Advanced Solid TumorsViroMissile, Inc.Phase 1 Recruiting78 enrolled
NCT00625456 2015-12-03Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid TumorsSillaJen, Inc.Phase 1 Completed23 enrolled
NCT01584284 2015-08-25Safety Study of Attenuated Vaccinia Virus (GL-ONC1)With Combination Therapy in Head & Neck CancerGenelux CorporationPhase 1 Completed19 enrolled